A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI

Chemotherapy Combined With High-dose Radiotherapy for Low Rectal Cancer Using MR Guided Linear Accelerator

NCT05338866 ·Status: ENROLLING_BY_INVITATION

Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer

NCT07394192 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Application of MRI in Identifying Myelosuppression Risk of Neoadjuvant Chemoradiotherapy for Rectal Cancer

NCT04970498 ·Status: UNKNOWN

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

NCT02640586 ·Status: UNKNOWN ·Phase: NA

Involve-site Radiotherapy Combined With Chemotherapy and Immunotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer

NCT07161115 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer

NCT06719414 ·Status: RECRUITING

Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer

NCT06613165 ·Status: RECRUITING

MRI Features in Neoadjuvant Treatment Decisions for Patients With Rectal Cancer

NCT05609149 ·Status: COMPLETED

Short-Course Radiotherapy Combined With Chemotherapy and Immunotherapy in Mid-Low Locally Advanced Rectal Cancer

NCT07397442 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

68Ga-FAPI-04 PET Imaging in Early Response Evaluation of Rectal Cancer Patients Treated With Immunotherapy

NCT05999227 ·Status: UNKNOWN ·Phase: NA

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer

NCT06293612 ·Status: COMPLETED

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

NCT06014944 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer

NCT04833387 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Multi-omics Model Predicts Efficacy of Preoperative Neoadjuvant Chemoradiotherapy Combined PD-1 Antibody Therapy for Locally Advanced Rectal Cancer

NCT05368051 ·Status: UNKNOWN

Study on the Applicability of CCR Criteria in Rectal Cancer

NCT06794099 ·Status: COMPLETED

TIME in Immunotherapy Combined With nCRT for Rectal Cancer

NCT05507112 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Pd1 Antibody Sintilimab ± Chemoradiotherapy for Locally Advanced Rectal Cancer

NCT04304209 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Prospective Trial for the Evaluation of Radiogenomics in Advanced Rectal Cancer

NCT04287400 ·Status: RECRUITING

Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET

NCT02233374 ·Status: COMPLETED ·Phase: NA

Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer

NCT06493240 ·Status: COMPLETED ·Phase: PHASE2

Total Neoadjuvant Therapy With PD-1 for Locally Advcancer Rectal Cancer

NCT07214142 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

NCT05523245 ·Status: RECRUITING

PCSK9 Inhibitor and PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy for pMMR/MSS Locally Advanced Rectal Cancer

NCT06933251 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

the Efficacy of MR-guided Online Adaptive Radiotherapy for Locally Advanced Rectal Cancer

NCT07080411 ·Status: NOT_YET_RECRUITING ·Phase: NA

MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer

NCT03714490 ·Status: RECRUITING ·Phase: PHASE2